Exploring the Halal Status of Cardiovascular, Endocrine, and Respiratory Group of Medications
- Author:
Azmi Sarriff
;
Hadeer Akram Abdul Razzaq
- Publication Type:Letter
- Keywords:
cardiovascular drugs, endocrine drugs, ethanol, halal, magnesium stearate respiratory drugs
- From:Malaysian Journal of Medical Sciences
2013;20(1):69-74
- CountryMalaysia
- Language:English
-
Abstract:
Muslim consumers have special needs in medical treatment that differ from non-Muslim consumers. In particular, there is a growing demand among Muslim consumers for Halal medications. This descriptive exploratory study aims to determine the Halal status of selected cardiovascular, endocrine, and respiratory medications stored in an out-patient pharmacy in a Malaysian governmental hospital. Sources of active ingredients and excipients for each product were assessed for Halal status based on available information obtained from product leaflets, the Medical Information Management System (MIMS) website, or manufacturers. Halal status was based on the products’ sources and categorized into Halal, Mushbooh, or Haram. The proportions of Halal, Mushbooh, and Haram products were at 19.1%, 57.1%, and 23.8%, respectively. The percentage of active ingredients for cardiovascular/endocrine products that were assessed as Haram was 5.3%; for respiratory medications, it was only 1.1%. For excipients, 1.7% and 4.8% fall under the category of Haram for cardiovascular/endocrine products and respiratory products, respectively. Ethanol and magnesium stearate were found to be the common substances that were categorized as Haram and Mushbooh.
